603122 Cowealth Medical China
- 5.36
- -0.05-0.92%
Cowealth Medical China News
HeFu China (603122.SH) will distribute cash dividends for the year 2023 on June 21, with a dividend of 0.06 yuan per share.
Hefu China (603122.SH) announced that it will distribute the annual report for 2023 on June 21, 2024.
By May 2024, the cumulative consolidated revenue of Hefu China (603122.SH) decreased by 13.26% year-on-year.
On June 7th, Gelunhui reported that the company's cumulative merged revenue for January-May 2024 was RMB 406 million, a 13.26% decrease from the same period last year.
Cowealth Medical China's Operating Income Falls 11% in January-April
Cowealth Medical China (SHA:603122) recorded a consolidated operating income of between January and April, sliding 11.12% from the prior year. Shares of the company fell nearly 2% in recent trade.
Hefu China (603122.SH): The cumulative consolidated revenue for January-April was 330 million yuan, a year-on-year decrease of 11.12%
On May 9, Ge Longhui China (603122.SH) announced that the company's cumulative consolidated revenue from January to April 2024 was RMB 332.672 million, down 11.12% from the consolidated revenue for the same period last year.
Hefu China (603122.SH) announced first-quarter results, net profit of 7.13 million yuan, a year-on-year decrease of 22.65%
Hefu China (603122.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 2.3 during the reporting period...
Capital Allocation Trends At Cowealth Medical ChinaLtd (SHSE:603122) Aren't Ideal
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Firstly, we'll want to see a proven return on capital employ
Hefu China (603122.SH): The cumulative consolidated revenue of January-March was 239 million yuan, a decrease of 10.69% year-on-year
On April 9, Ge Longhui China (603122.SH) announced that the company's cumulative consolidated revenue from January to March 2024 was RMB 23,8622,200, down 10.69% from the consolidated revenue for the same period last year.
Hefu China (603122.SH): Net profit in 2023 fell 42.96% year on year, and plans to pay 10 0.60 yuan
On March 22, Ge Longhui China (603122.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 1,093 billion yuan, a year-on-year decrease of 14.62%; net profit attributable to shareholders of listed companies was 47,1889 million yuan, a year-on-year decrease of 42.96%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 469.192 million yuan, a year-on-year decrease of 38.18%; and basic earnings per share were 0.12 yuan. On March 22, 2024, the board of directors of the company proposed that the company distribute cash dividends to common shareholders to implement the equity registration date
Hefu China (603122.SH): cumulative consolidated revenue of 150 million yuan in January-February increased 1.2% year-on-year
On March 8, Ge Longhui China (603122.SH) announced that the company's cumulative consolidated revenue for January-February 2024 was RMB 153.7889 million, an increase of 1.20% over the consolidated revenue for the same period last year.
Hefu China (603122.SH): Zhang Chen resigns as financial director
Hefu China (603122.SH) issued an announcement. Du Jiahai, the company's deputy general manager, and Zhang Chen, deputy general manager and financial director...
Is Cowealth Medical China Co.,Ltd.'s (SHSE:603122) Stock On A Downtrend As A Result Of Its Poor Financials?
Cowealth Medical ChinaLtd (SHSE:603122) has had a rough three months with its share price down 24%. We decided to study the company's financials to determine if the downtrend will continue as the lo
Hefu China (603122.SH): Consolidated revenue of 1,099 billion yuan from January to December 2023 decreased by 14.11% year-on-year
On January 10, Gelonghui China (603122.SH) announced that the company's consolidated revenue for January-December 2023 was RMB 1,099 billion, down 14.11% from the consolidated revenue for the same period last year.
Hefu China (603122.SH): January-November consolidated revenue of 982 million yuan decreased 14.75% year-on-year
Hefu China (603122.SH) announced that the company's consolidated revenue from January to November 2023 was RMB 9...
Hefu China (603122.SH): Consolidated revenue from January to October was 910 million yuan, a year-on-year decrease of 13.47%
Hefu China (603122.SH) announced that the company's consolidated operating income from January to October 2023 is for the people...
Hefu China (603122.SH): Net profit of 44.07 million yuan in the first three quarters fell 18.77% year-on-year
Glonghui, October 26丨Hefu China (603122.SH) announced its third quarter report. Revenue was 833 million yuan, down 12.88% year on year, net profit was 44.07 million yuan, down 18.77% year on year, net profit was 44.07 million yuan, down 18.77% year on year, after deducting non-net profit of 39.076 million yuan, down 26.85% year on year, and basic earnings per share were 0.11 yuan.
Hefu China (603122.SH): January-September consolidated revenue decreased by 12.88% year-on-year
Glonghui, Oct. 11丨Hefu China (603122.SH) announced that the company's consolidated revenue from January to September 2023 was RMB 833 million, a decrease of 12.88% over the same period last year.
Hefu China (603122.SH): Consolidated revenue of 833 million yuan from January to September decreased by 12.88% year-on-year
Hefu China (603122.SH) announced that the company's consolidated operating income from January to September 2023 was RMB...
Hefu China (603122.SH): The company has always maintained the self-discipline of all sales expenses being less than 7%
Glonghui September 15 | Hefu China (603122.SH) said at the semi-annual performance briefing that sales expenses have increased slightly this year, mainly due to the entry into the market of independently developed and patented information technology products and increased business personnel in promotion and empty areas, yet the company has always maintained a self-discipline of less than 7% of all sales expenses. The company has always used service innovation and technological innovation to provide customers with a dual-effect integrated service to reduce costs and increase efficiency.
Hefu China (603122.SH): A supply chain network with more than 1,500 original manufacturers and general generations, covering 17,000 types of inspection items, and covering 95% of medical consumables
Gelonghui, September 15 | Hefu China (603122.SH) said at the semi-annual performance briefing that the company has a complete supply chain platform. It has a supply chain network with more than 1,500 original manufacturers and general generations, covering 17,000 inspection items, and covering 95% of medical consumables to meet customer needs. At the same time, it actively promotes the national policy requirements of the two-tier ticket system, reduces the profits of multi-level agents, and creates a win-win cooperation model for the original factory, Hefu and customers.
Hefu China (603122.SH) released first-half results, net profit of 309.26,800 yuan, down 15.3% year on year
Hefu China (603122.SH) released the 2023 semi-annual report, with the company's operating income of 565 million yuan,...
Analysis
Price Target
No Data
